Recordati Industria Chimica e Farmaceutica Logo

Recordati Industria Chimica e Farmaceutica

ISIN: IT0003828271 | Ticker: REC | LEI: 815600FBF92FD3531704

About Recordati Industria Chimica e Farmaceutica

Company Description

Recordati is a well-established international pharmaceutical group dedicated to the research, development, manufacturing and marketing of pharmaceuticals with more than 4,300 employees listed on the Italian Stock Exchange since 1984. Headquartered in Milan, Italy, Recordati has operations in Europe, Russia and the other C.I.S. countries, in Ukraine, Turkey, North Africa, the United States of America, Canada, Mexico, some South American countries, Japan and Australia.

Recordati offers a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized segment dedicated to treatments for rare diseases. An efficient field force of medical representatives and orphan drug representatives promotes its products in about 150 markets.

Served area

Worldwide

Headcount

4,300

Headquarters

Via M. Civitali 1, 20148 Milano – Italy

Filings & Publications

2032

Report Q1 H1 Q3 FY
Consolidated Report ITA
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

2022

Report Q1 H1 Q3 FY
Consolidated Report ENG
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

2021

Report Q1 H1 Q3 FY
Consolidated Report ENG ITA
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

Shareholder information

Shares outstanding

209,125,156

IPO

Jan. 1, 1984

Stock exchange(s)

Borsa Italiana

Contact Investor Relations department

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.